Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 2, 2000, Pages 469-475

  Goldenberg, Robert L ^a   Klebanoff, Mark ^a   Carey, J Christopher ^a   MacPherson, Cora ^a   Leveno, Kenneth J ^a   Moawad, Atef H ^a   Sibai, Baha ^a   Heine, R P ^a   Ernest, J M ^a   Dombrowski, Mitchell P ^a   Miodovnik, Menachem ^a   Wapner, Ronald J ^a   Iams, Jay D ^a   Langer, Oded ^a   O'Sullivan, Mary J ^a   Roberts, James M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bacterial vaginosis; Fetal fibronectin; Preterm birth; Trichomonas vaginalis

Indexed keywords

ANTIBIOTIC AGENT; FIBRONECTIN; PLACEBO;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEGRO; NULLIPARA; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; TRICHOMONAS VAGINALIS; VAGINA; VAGINITIS;

EID: 0033848868     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.106073     Document Type: Article

References (19)

1. The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth
2. The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery
3. The preterm prediction study: The value of new vs standard risk factors in predicting early and all spontaneous preterm birth
4. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
5. A new test for diagnosis and prediction of preterm delivery
6. Metronidazole did not prevent preterm birth in asymptomatic women with bacterial vaginosis
7. Reliability of diagnosis of bacterial vaginosis is improved by a standardized method of Gram stain interpretation
8. Is oncofetal fibronectin a trophoblast glue for human implantation?
9. A review of premature birth and subclinical infection
10. The preterm prediction study: Fetal fibronectin, bacterial vaginosis, and peripartum infection
11. Detection of tumor necrosis factor-α, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome
12. Association between bacterial vaginosis and fetal fibronectin at 24-29 weeks' gestation
13. Does prenatal care improve birth outcomes? A critical review
14. The preterm prediction study: Quantitative fetal fibronectin (FFN) values and the prediction of spontaneous preterm birth (SPTB)
15. The preterm prediction study: Significance of vaginal infections
16. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis
17. Prediction of preterm delivery by fetal fibronectin: A meta-analysis
18. Markers of preterm birth
19. Preterm labor: Emerging role of genital tract infections